← Eichor
Study identifier: NCT06532279 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Condition: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8  ·  Sponsor: NRG Oncology

PhasePhase 2
Planned participants98
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This phase II trial compares the effectiveness of adding BMX-001 to usual symptom management versus usual symptom management alone for reducing oral mucositis in patients who are receiving chemoradiation for head and neck cancer. Oral mucositis (inflammation and mouth sores) is a common side effect of chemoradiation that can cause pain and difficulty swallowing. Usual management of these side effects typically consists of using mouth rinses and pain medications during treatment and for several weeks after completion of treatment. BMX-001 neutralizes harmful substances in the body, preventing damage to macromolecules such as DNA and minimizes free radical-related toxicity in normal tissues. Adding BMX-001 to usual symptom management may be more effective than usual symptom management alone at reducing oral mucositis in patients receiving chemoradiation for head and neck cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (153)

Arizona Center for Cancer Care - GilbertGilbert, Arizona, United StatesRecruiting
Arizona Center for Cancer Care-PeoriaPeoria, Arizona, United StatesRecruiting
Arizona Center for Cancer Care - PhoenixPhoenix, Arizona, United StatesRecruiting
Arizona Center for Cancer Care - ScottsdaleScottsdale, Arizona, United StatesRecruiting
Arizona Center for Cancer Care-SurpriseSurprise, Arizona, United StatesRecruiting
Arizona Center for Cancer CareTempe, Arizona, United StatesRecruiting
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - JonesboroJonesboro, Arkansas, United StatesRecruiting
Keck Medicine of USC Buena ParkBuena Park, California, United StatesSuspended
UC San Diego Health System - EncinitasEncinitas, California, United StatesRecruiting
UC San Diego Moores Cancer CenterLa Jolla, California, United StatesRecruiting
Los Angeles General Medical CenterLos Angeles, California, United StatesSuspended
USC / Norris Comprehensive Cancer CenterLos Angeles, California, United StatesSuspended

+ 141 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06532279